CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 28 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $46,000 | -39.5% | 16,246 | 0.0% | 0.00% | – |
Q4 2021 | $76,000 | +72.7% | 16,246 | 0.0% | 0.00% | – |
Q3 2021 | $44,000 | -4.3% | 16,246 | 0.0% | 0.00% | – |
Q2 2021 | $46,000 | -6.1% | 16,246 | 0.0% | 0.00% | – |
Q1 2021 | $49,000 | +2.1% | 16,246 | 0.0% | 0.00% | – |
Q4 2020 | $48,000 | -7.7% | 16,246 | 0.0% | 0.00% | – |
Q3 2020 | $52,000 | -3.7% | 16,246 | 0.0% | 0.00% | – |
Q2 2020 | $54,000 | -8.5% | 16,246 | 0.0% | 0.00% | – |
Q1 2020 | $59,000 | -29.8% | 16,246 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $84,000 | -12.5% | 16,246 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $96,000 | -10.3% | 16,246 | -3.4% | 0.00% | 0.0% |
Q2 2019 | $107,000 | +11.5% | 16,812 | +1.3% | 0.00% | 0.0% |
Q1 2019 | $96,000 | -8.6% | 16,604 | -0.1% | 0.00% | 0.0% |
Q4 2018 | $105,000 | +10.5% | 16,626 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $95,000 | -6.9% | 16,626 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $102,000 | -8.1% | 16,626 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $111,000 | -9.8% | 16,626 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $123,000 | -52.5% | 16,626 | -54.6% | 0.00% | -50.0% |
Q3 2017 | $259,000 | 0.0% | 36,626 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $259,000 | +2.0% | 36,626 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $254,000 | +26.4% | 36,626 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $201,000 | -36.6% | 36,626 | -42.1% | 0.00% | -33.3% |
Q3 2016 | $317,000 | -12.9% | 63,305 | -13.1% | 0.00% | -25.0% |
Q2 2016 | $364,000 | +12.0% | 72,826 | +0.5% | 0.00% | 0.0% |
Q1 2016 | $325,000 | -14.7% | 72,446 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $381,000 | -8.9% | 72,446 | 0.0% | 0.00% | -20.0% |
Q3 2015 | $418,000 | -19.3% | 72,446 | 0.0% | 0.01% | -16.7% |
Q2 2015 | $518,000 | +9.1% | 72,446 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $475,000 | -45.2% | 72,446 | -50.0% | 0.01% | -14.3% |
Q4 2014 | $866,000 | +12.8% | 144,892 | -6.8% | 0.01% | -46.2% |
Q3 2014 | $768,000 | -13.6% | 155,402 | -21.4% | 0.01% | -18.8% |
Q2 2014 | $889,000 | 0.0% | 197,646 | 0.0% | 0.02% | -15.8% |
Q1 2014 | $889,000 | -12.0% | 197,646 | 0.0% | 0.02% | -44.1% |
Q4 2013 | $1,010,000 | -47.1% | 197,646 | -53.1% | 0.03% | -44.3% |
Q3 2013 | $1,910,000 | -14.9% | 421,550 | -4.1% | 0.06% | +1.7% |
Q2 2013 | $2,245,000 | – | 439,364 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 896,170 | $4,615,000 | 3.22% |
Ariel Investments | 1,010,220 | $5,203,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $942,000 | 0.01% |
Anfield Capital Management, LLC | 4,530 | $23,000 | 0.01% |
Financial Gravity Asset Management, Inc. | 2,000 | $10,000 | 0.01% |
Oakworth Capital, Inc. | 3,052 | $16,000 | 0.00% |
BAILARD, INC. | 11,816 | $61,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 860,319 | $4,431,000 | 0.00% |
Renaissance Technologies | 469,338 | $2,417,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 98,192 | $506,000 | 0.00% |